MYCN and neuroblastoma: The best known example is the compound 10058-F4, a c-Myc inhibitor that also prevented MYCN/MAX hetero-dimerization in vitro [32], inhibited tumour growth and improved survival in a MYCN transgenic mouse model of neuroblastoma [33].